Bausch Health Companies Inc. (NYSE: BHC), Laval, Canada – FDA Inspections

Inspection records and compliance data for Bausch Health Companies Inc. in Laval. 10 FDA inspections on record, 1 Form 483, last inspected January 19, 2024. Publicly traded as NYSE: BHC.

Company Profile

This profile covers Bausch Health Companies Inc. based in Laval, Canada.

FDA Inspection History

FDA inspections: 10
OAI: 0
VAI: 6
NAI: 4
Form 483s: 1
Warning letters: 0

First inspected October 30, 2008. Last inspected January 19, 2024.

Most cited issue areas

Procedures not in writing, fully followed2 inspections
SOPs not followed / documented1 inspection

FDA inspections (10)

Date	Result	FDA center(s)	Insp. #
January 19, 2024	NAI	Human Drugs · Drug Quality Assurance	1229765
September 29, 2022	NAI	Human Drugs · Drug Quality Assurance	1190487
September 19, 2019	NAI	Human Drugs · Drug Quality Assurance	1108379
April 26, 2019	VAI	Human Drugs · New Drug Evaluation	1089615
February 17, 2017	NAI	Human Drugs · Drug Quality Assurance	1007199
February 20, 2015	VAI	Human Drugs · Drug Quality Assurance	914426
June 17, 2014	VAI	Human Drugs · Drug Quality Assurance	887846
September 20, 2013	VAI	Human Drugs · Drug Quality Assurance	850664
July 28, 2011	VAI	Human Drugs · Drug Quality Assurance	750079
October 30, 2008	VAI	Human Drugs · Drug Quality Assurance	545950

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)

Health Canada · 1 inspection · last October 1, 2014

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Bora Pharmaceutical Services Inc.

Catalent Ontario Limited

Delpharm Montreal Inc.

Trillium Health Care Products Inc.

Halo Pharmaceutical Canada Inc

Voyant Beauty, Inc.

CRESCITA SKIN SCIENCES INC.

G Production, Inc.

Kenvue Canada Inc.

KDC/ONE Development Corporation, Inc.